-
Je něco špatně v tomto záznamu ?
The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category
M. Kotrova, E. Fronkova, M. Svaton, D. Drandi, F. Schön, P. Hoogeveen, J. Hancock, A. Skotnicova, A. Schilhabel, C. Eckert, E. Clappier, G. Cazzaniga, BW. Schäfer, JJM. van Dongen, M. Ritgen, C. Pott, VHJ. van der Velden, J. Trka, M. Brüggemann
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu dopisy
Grantová podpora
NU20-03-00284
Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
GA UK 318321
Grantová Agentura, Univerzita Karlova (Charles University Grant Agency)
TRANSCAN/BMBF 179, the NOVEL Consortium
Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
NLK
ProQuest Central
od 2000-01-01 do Před 1 rokem
Open Access Digital Library
od 1997-01-01
Nursing & Allied Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
- MeSH
- kvantitativní polymerázová řetězová reakce metody MeSH
- lidé MeSH
- reziduální nádor * diagnóza genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
Austrian Academy of Sciences CeMM Research Center for Molecular Medicine Vienna Austria
Bristol Genetics Laboratory Southmead Hospital Bristol UK
Department of Hematology University Hospital Zürich Switzerland
Department of Immunology Leiden University Medical Center Leiden the Netherlands
Department of Internal Medicine 2 University Hospital Schleswig Holstein Kiel Germany
Department of Pediatric Hematology and Oncology Charité Universitätsmedizin Berlin Berlin Germany
German Cancer Consortium Heidelberg Germany
Hematology Laboratory Saint Louis Hospital Assistance Publique Hôpitaux de Paris Paris France
St Anna Children's Cancer Research Institute Vienna Austria
Tettamanti Cente Fondazione IRCCS San Gerardo dei Tintori Monza Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019908
- 003
- CZ-PrNML
- 005
- 20241024111027.0
- 007
- ta
- 008
- 241015s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41375-024-02265-z $2 doi
- 035 __
- $a (PubMed)38760480
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kotrova, Michaela $u Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany $1 https://orcid.org/0000000153941072 $7 xx0209776
- 245 14
- $a The gray area of RQ-PCR-based measurable residual disease: subdividing the "positive, below quantitative range" category / $c M. Kotrova, E. Fronkova, M. Svaton, D. Drandi, F. Schön, P. Hoogeveen, J. Hancock, A. Skotnicova, A. Schilhabel, C. Eckert, E. Clappier, G. Cazzaniga, BW. Schäfer, JJM. van Dongen, M. Ritgen, C. Pott, VHJ. van der Velden, J. Trka, M. Brüggemann
- 650 12
- $a reziduální nádor $x diagnóza $x genetika $7 D018365
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $x metody $7 D060888
- 655 _2
- $a dopisy $7 D016422
- 700 1_
- $a Fronkova, Eva $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000269008145 $7 xx0105058
- 700 1_
- $a Svaton, Michael $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $u St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria $u Austrian Academy of Sciences, CeMM Research Center for Molecular Medicine, Vienna, Austria $1 https://orcid.org/0000000329663687
- 700 1_
- $a Drandi, Daniela $u Hematology Division, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
- 700 1_
- $a Schön, Felix $u Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
- 700 1_
- $a Hoogeveen, Patricia $u Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
- 700 1_
- $a Hancock, Jeremy $u Bristol Genetics Laboratory, Southmead Hospital, Bristol, UK
- 700 1_
- $a Skotnicova, Aneta $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Schilhabel, Anke $u Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
- 700 1_
- $a Eckert, Cornelia $u Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany $u German Cancer Consortium (DKTK), and German Cancer Research Center (DKFZ), Heidelberg, Germany
- 700 1_
- $a Clappier, Emmanuelle $u Hematology Laboratory, Saint Louis Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
- 700 1_
- $a Cazzaniga, Gianni $u Tettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy $1 https://orcid.org/0000000329554528
- 700 1_
- $a Schäfer, Beat W $u Department of Hematology, University Hospital, Zürich, Switzerland $1 https://orcid.org/0000000159882915
- 700 1_
- $a van Dongen, Jacques J M $u Department of Immunology, Leiden University Medical Center (LUMC), Leiden, the Netherlands $1 https://orcid.org/0000000236507087
- 700 1_
- $a Ritgen, Matthias $u Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
- 700 1_
- $a Pott, Christiane $u Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany $1 https://orcid.org/0009000592608340
- 700 1_
- $a van der Velden, Vincent H J $u Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands $1 https://orcid.org/0000000194573763
- 700 1_
- $a Trka, Jan $u CLIP-Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000295278608 $7 xx0036261
- 700 1_
- $a Brüggemann, Monika $u Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany. m.brueggemann@med2.uni-kiel.de $1 https://orcid.org/0000000155145010 $7 xx0317361
- 773 0_
- $w MED00003138 $t Leukemia $x 1476-5551 $g Roč. 38, č. 7 (2024), s. 1617-1620
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38760480 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111021 $b ABA008
- 999 __
- $a ok $b bmc $g 2202241 $s 1231881
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 38 $c 7 $d 1617-1620 $e 20240517 $i 1476-5551 $m Leukemia $n Leukemia $x MED00003138
- GRA __
- $a NU20-03-00284 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
- GRA __
- $a GA UK 318321 $p Grantová Agentura, Univerzita Karlova (Charles University Grant Agency)
- GRA __
- $a TRANSCAN/BMBF 179, the NOVEL Consortium $p Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
- LZP __
- $a Pubmed-20241015